The page is the record's research on the issuer — no analyst, no rating, no view.

Rakovina Therapeutics Inc. (RKV) — research page

CA · ca-cm-kg/TSXV/RKV · as of 2026-11-06

Identity and listing

The issuer is Rakovina Therapeutics Inc., listed on the TSXV under ticker RKV, with LEI 254900O0YVEUNI9UM016. The ISIN is not on the record. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is British Columbia (CA-BC). The issuer is listed and not halted.

fieldvaluesource · read date
nameRakovina Therapeutics Inc.source · 2026-11-06
exchangeTSXVsource · 2026-11-06
tickerRKVsource · 2026-11-06
ISINnot on the record
LEI254900O0YVEUNI9UM016source · 2026-11-06
security typeCorporatesource · 2026-11-06
segmentnot on the record
sectorLife Sciencessource · 2026-11-06
jurisdictionBritish Columbia (CA-BC)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 28 filings in the twelve months to 2026-11-06, across 24 filing days. The filings are 21 newswire releases, 4 exchange bulletins and 3 financial statements. The median gap between filing days is 12 days. The latest filing is a newswire release dated 2026-11-05, 1 day before the record date. The TSXV median cadence gap is 19 days, and the TSXV median latency is 17.0 days. The Life Sciences sector median cadence gap is 17.5 days, and the sector median latency is 14 days. The TSXV median filings count is 9, and the sector median filings count is 7.0.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer28121
exchange median: TSXV (1427 issuers)91917
sector median: Life Sciences (200 issuers)717.514
datetypecategoryfiling
2026-11-05newswire_releaseRakovina Therapeutics Announces Shares for Debt
2026-11-05newswire_releaseRakovina Therapeutics to Present Brain-Penetrant ATR
2026-11-05newswire_releaseRakovina Therapeutics Announces Shares for Debt
2026-10-28newswire_releaseRakovina Therapeutics and Celvion Therapeutics Complete AI
2026-10-22newswire_releaseRakovina Therapeutics and Variational AI Advance

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Davidson & Company LLP. The auditor's location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting, name change, domicile change or segment move events. The issuer is listed and not halted.

Orderability

Under rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, chapter as of 2026-11-04, both client categories return signal ACM-200 and the outcome is determinable: Paragraph (o) of the definition and Paragraph (q) of the definition.

client categoryoutcome
Paragraph (o) of the definitionACM-200
Paragraph (q) of the definitionACM-200

rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

Open research

No openly published research notes were found. The count is 0.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The vintage of this market is not sealed. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.tsx.com/json/company-directory/search/tsxv/^* (identity.exchange)
10.2
https://api.gleif.org/api/v1/lei-records/254900O0YVEUNI9UM016 (identity.jurisdiction)
10.3
https://www.tsx.com/en/resource/571 (identity.sector)
10.4
https://mcp.ca-cm-kg.ai/events/TSXV/RKV (the disclosure lines)
10.5
https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
10.6
https://www.biospace.com/press-releases/rakovina-therapeutics-announces-q2-2026-financial-results-and-provides-corporate-update (the auditor)
10.7
https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
10.8
https://mcp.ca-cm-kg.ai/record/TSXV/RKV (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"RKV","exchange":"TSXV"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:449727a49ac2a9f4.